Cargando…

Serum Total Antioxidant Capacity and Enzymatic Defence of Dogs with Chronic Heart Failure and Atrial Fibrillation: A Preliminary Study

INTRODUCTION: Atrial fibrillation may potentially contribute to oxidative stress to a greater extent than chronic heart failure. The aim of the study was to compare the serum total antioxidant capacity and enzymatic antioxidant defence of dogs with chronic heart failure and atrial fibrillation with...

Descripción completa

Detalles Bibliográficos
Autores principales: Michałek, Marcin, Tabiś, Aleksandra, Noszczyk-Nowak, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497747/
https://www.ncbi.nlm.nih.gov/pubmed/32984636
http://dx.doi.org/10.2478/jvetres-2020-0047
_version_ 1783583380706689024
author Michałek, Marcin
Tabiś, Aleksandra
Noszczyk-Nowak, Agnieszka
author_facet Michałek, Marcin
Tabiś, Aleksandra
Noszczyk-Nowak, Agnieszka
author_sort Michałek, Marcin
collection PubMed
description INTRODUCTION: Atrial fibrillation may potentially contribute to oxidative stress to a greater extent than chronic heart failure. The aim of the study was to compare the serum total antioxidant capacity and enzymatic antioxidant defence of dogs with chronic heart failure and atrial fibrillation with those of subjects with chronic heart failure and sinus rhythm and healthy controls. MATERIAL AND METHODS: A total of 33 dogs were divided into three groups: dogs with chronic heart failure and atrial fibrillation (CHF + AF; n = 12), chronic heart failure and sinus rhythm (CHF + SR; n = 9), and healthy controls (n = 12). Serum total antioxidant capacity (TAC), serum CuZn-superoxide dismutase (SOD) and catalase, and plasma glutathione peroxidase (GPx) activity were determined. RESULTS: SOD activity and serum TAC were significantly lower in the study groups than in control animals. Catalase activity was significantly higher and plasma GPx activity significantly lower in dogs with CHF + AF compared with the CHF + SR and control dogs. CONCLUSION: The results suggest that chronic heart failure in dogs significantly impacts the serum TAC and the antioxidant enzymatic defence, while plasma GPx activity is markedly lower in dogs with chronic heart failure and atrial fibrillation. The role of that imbalance needs further investigation.
format Online
Article
Text
id pubmed-7497747
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-74977472020-09-25 Serum Total Antioxidant Capacity and Enzymatic Defence of Dogs with Chronic Heart Failure and Atrial Fibrillation: A Preliminary Study Michałek, Marcin Tabiś, Aleksandra Noszczyk-Nowak, Agnieszka J Vet Res Research Article INTRODUCTION: Atrial fibrillation may potentially contribute to oxidative stress to a greater extent than chronic heart failure. The aim of the study was to compare the serum total antioxidant capacity and enzymatic antioxidant defence of dogs with chronic heart failure and atrial fibrillation with those of subjects with chronic heart failure and sinus rhythm and healthy controls. MATERIAL AND METHODS: A total of 33 dogs were divided into three groups: dogs with chronic heart failure and atrial fibrillation (CHF + AF; n = 12), chronic heart failure and sinus rhythm (CHF + SR; n = 9), and healthy controls (n = 12). Serum total antioxidant capacity (TAC), serum CuZn-superoxide dismutase (SOD) and catalase, and plasma glutathione peroxidase (GPx) activity were determined. RESULTS: SOD activity and serum TAC were significantly lower in the study groups than in control animals. Catalase activity was significantly higher and plasma GPx activity significantly lower in dogs with CHF + AF compared with the CHF + SR and control dogs. CONCLUSION: The results suggest that chronic heart failure in dogs significantly impacts the serum TAC and the antioxidant enzymatic defence, while plasma GPx activity is markedly lower in dogs with chronic heart failure and atrial fibrillation. The role of that imbalance needs further investigation. Sciendo 2020-07-28 /pmc/articles/PMC7497747/ /pubmed/32984636 http://dx.doi.org/10.2478/jvetres-2020-0047 Text en © 2020 M. Michałek et al., published by Sciendo http://creativecommons.org/licenses/by-nc-nd/3.0 This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
spellingShingle Research Article
Michałek, Marcin
Tabiś, Aleksandra
Noszczyk-Nowak, Agnieszka
Serum Total Antioxidant Capacity and Enzymatic Defence of Dogs with Chronic Heart Failure and Atrial Fibrillation: A Preliminary Study
title Serum Total Antioxidant Capacity and Enzymatic Defence of Dogs with Chronic Heart Failure and Atrial Fibrillation: A Preliminary Study
title_full Serum Total Antioxidant Capacity and Enzymatic Defence of Dogs with Chronic Heart Failure and Atrial Fibrillation: A Preliminary Study
title_fullStr Serum Total Antioxidant Capacity and Enzymatic Defence of Dogs with Chronic Heart Failure and Atrial Fibrillation: A Preliminary Study
title_full_unstemmed Serum Total Antioxidant Capacity and Enzymatic Defence of Dogs with Chronic Heart Failure and Atrial Fibrillation: A Preliminary Study
title_short Serum Total Antioxidant Capacity and Enzymatic Defence of Dogs with Chronic Heart Failure and Atrial Fibrillation: A Preliminary Study
title_sort serum total antioxidant capacity and enzymatic defence of dogs with chronic heart failure and atrial fibrillation: a preliminary study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497747/
https://www.ncbi.nlm.nih.gov/pubmed/32984636
http://dx.doi.org/10.2478/jvetres-2020-0047
work_keys_str_mv AT michałekmarcin serumtotalantioxidantcapacityandenzymaticdefenceofdogswithchronicheartfailureandatrialfibrillationapreliminarystudy
AT tabisaleksandra serumtotalantioxidantcapacityandenzymaticdefenceofdogswithchronicheartfailureandatrialfibrillationapreliminarystudy
AT noszczyknowakagnieszka serumtotalantioxidantcapacityandenzymaticdefenceofdogswithchronicheartfailureandatrialfibrillationapreliminarystudy